Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
The aim of this phase I/II trial is to determine the dose of daunorubicine to be associated with cytarabine and Imatinib for induction therapy in patients with chronic myelogenous leukemia in myeloid acute phase.
Inclusion criteria
- Chronic myeloid leukemia